Patient Characteristics in Daily Radiological Practice of Gadovist® Application (PATRON)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00874640

Enrollment

3711

Registered

2009-04-02

Start date

2009-03-31

Completion date

2011-11-30

Last updated

2014-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epidemiologic Factors

Keywords

Drug utilization review

Brief summary

To evaluate patient characteristics in the current daily radiological practice of Gadovist application. Special focus will be laid on the individual risk factors of patients, the indications for and the dose of Gadovist application. Secondary objective is to prove the known safety profile (especially rare adverse events) of Gadovist and to collect data on handling problems with different application forms (one questionnaire per center).

Interventions

BIOLOGICALGadobutrol (Gadovist, BAY86-4875)

Patients with indication for a MRT or MR-Angiography and for whom the radiologist has decided to use the contrast medium gadobutrol

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

7 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients with indication for a MRT or MR-Angiography and for whom the radiologist has decided to use the contrast medium Gadovist

Exclusion criteria

* No

Design outcomes

Primary

Measure	Time frame
Patient Profile	At day of application

Secondary

Measure	Time frame
Dosing of Gadovist in different indications	At time of application
Adverse Events	Throughout and after application

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026